Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Don't have an account? Register Here
<h1>India Updates Customs Duty Exemptions for Medicines Under Patient Assistance Programs by Novartis, Sandoz, and Pfizer.</h1> The Government of India, through the Ministry of Finance, has issued Notification No. 41/2020-Customs, further amending Notification No. 16/2017-Customs dated 20th April 2017. This amendment pertains to customs duty exemptions for specific medicines provided under various Patient Assistance Programmes (PAPs) operated by pharmaceutical companies. The notification updates the entries in the exemption table, including programs like 'Win for Patients- Cancer Care/Umaang' by Novartis and Sandoz, and several assistance programs by Pfizer. This amendment is enacted under the powers conferred by the Customs Act, 1962, in the public interest.